Composition for treatment of gynecological disease in women (variants)

FIELD: medicine, gynecology, phytotherapy, pharmaceutical industry.

SUBSTANCE: invention relates to composition used in treatment of gynecological diseases in women. The composition for treatment of gynecological diseases in women comprises a mixture of the following dry medicinal plants: pot-marigold flowers, clinging bedstraw herb, swampy marsh cinquefoil herb, walnut walls, licorice roots and fenestrate Saint-John's-wort herb taken in the definite ratio of components. Also, the composition for treatment of gynecological diseases in women comprises a mixture of 30-40% alcoholic tinctures of medicinal plants: pot-marigold flowers, clinging bedstraw herb, swampy marsh cinquefoil herb, walnut walls, licorice roots and fenestrate Saint-John's-wort herb taken in the definite ratio. Proposed compositions promote to effective treatment of gynecological diseases in women.

EFFECT: valuable medicinal properties of compositions.

4 cl, 6 ex

 

The invention relates to chemical-pharmaceutical industry, namely the creation of the preparation of plant materials for the treatment of gynecological disorders in women.

Breast is one of the most common diseases in women. For the treatment of mastitis using hormonal drugs: norcolut, methyltestosterone, thyroxine, danazol and others (Imamology, 1996, No. 4, p.9-14).

Currently, the basis of non-operative treatment of uterine fibroids are hormone drugs.

The frequency of gynecological diseases in women of reproductive age endometriosis ranks third after inflammatory diseases of appendages and fibroids. For the treatment of endometriosis proposed a number of drugs: donoval, danogen, marvelon, etc.

The disadvantages of the above means is that these drugs have different side effects and toxic effects. In addition, the high frequency of recurrence of the disease after long-term hormonal means causes the search for new means and methods of treatment, one of which is the integrated use of phytotherapeutic effects.

The present invention is to provide a composition for the treatment of gynecological diseases taking into account the complex effects on the body and proyavlyaya is anti-inflammatory, analgesic, diuretic, antispasmodic and antiseptic properties.

The problem is solved by a group of inventions aimed at solving one problem and achieving the same result.

The proposed composition for the treatment of gynecological diseases in women, including a mix of dried medicinal plants: calendula (flowers), cleaver (grass), marsh cinquefoil (grass), walnut (partitions), licorice (root) and Hypericum perforatum (grass), taken in the following ratio, in part:

calendula officinalis (flowers)1,0-2,5
cleaver (grass)0.5 to 1.5
the cowberry (grass)1,5-3,0
walnut (septum)1,5-3,0
licorice (root)0.5 to 1.5
St. John's wort (herb)0.5 to 1.5

Composition for the treatment of gynecological disorders in women may additionally contain clover medicinal 0,5-1,5 hours

The proposed composition for the treatment of gynecological diseases in women, including a mix of 30-40% alcohol tinctures of medicinal plants calendula (flowers), cleaver grass), the marsh cinquefoil (grass), walnut (partitions), licorice (root) and Hypericum perforatum (grass), taken in the following ratio, including:

tincture of calendula (flowers)1,0-2,5
tincture cleaver (grass)0.5 to 1.5
tincture of marsh cinquefoil (grass)1,5-3,0
tincture of walnut (septum)1,5-3,0
the licorice (root)0.5 to 1.5
tincture of St. John's wort (herb)0.5 to 1.5

Composition for the treatment of gynecological disorders in women may additionally contain clover tincture dosage 0,5-1,5 hours

The composition in the form of collection is made from dry raw materials in the indicated proportions.

Composition in the form of a mixture of tincture is prepared as follows: pre-each medicinal plant insist on 30-40% alcohol at a ratio of dry raw material: solvent 1:5, respectively and after filtering are mixed in specified proportions.

How to use:

1. 10 grams of minced collection pour 1-2 cups of boiling water, boil for 5 minutes, cool, strain, squeeze. To take during the day in three receptions for 30 minutes before eating or h is cut 1-1,5 hours after a meal.

2. In the case of tinctures take 10 ml of a mixture of 0.5 glass of water 3 times a day 30 minutes before meals or after 1-1,5 hours after a meal.

Persons over 60 years of age to take 1/2 dose.

Contraindications: individual intolerance of the components of plant materials.

Chemical analysis showed that the infusion or tincture contains ascorbic acid, carotenoids, vitamins of group b, P, PP, E, K; trace elements: copper, manganese, zinc, cobalt, chromium, selenium, Nickel, strontium, molybdenum, boron, iodine, barium, vanadium and iron.

Action spectrum composition: diffuse and nodular breast disease, fibroids and other benign diseases of the uterus, endometriosis, adhesions, benign tumors of the ovaries and mammary glands, cysts in various organs.

Tests were conducted on volunteers.

Example 1. Patient D. (21)

The original diagnosis of a cyst of the right ovary of medium size; micropolicies left ovary.

Therapy: admission fee in the form of a mixture of tinctures in accordance with the scheme within 4 months.

The results of the Wellness policy: according to the U.S. cystic changes in the ovaries is not found.

Example 2. Patient C. (52)

Original diagnosis: multiple fibroids large size (17 weeks), bilateral nodal mastopathy.

Therapy: a dry collection of this scheme during the 8th month is.

The results of the Wellness course:

the breast on the mammogram is not detected;

the size of the fibroids fell to 8-9 weeks.

Example 3. Patient E. (57 years)

Original diagnosis: bilateral fibrocystic disease of the breast.

Complaints: severe chest pain, discharge, swollen lymph nodes in the armpits.

Therapy: admission fee in the form of a mixture of tincture of this scheme in the next 6 months.

The results of the Wellness course: breast on the mammogram was not found.

Example 4. The patient Century (42)

The original diagnosis of fibroadenoma of the right breast, diffuse breast left breast.

Complaints: severe pain in the right breast, discharge; pain in left breast.

Therapy: admission fee in the form of a mixture of tinctures in accordance with the scheme within 4 months.

The results of the Wellness course:

fibroadenoma significantly decreased;

breast left breast on the mammogram is not detected;

pain weak, fickle.

Therapy: admission fee in the form of a mixture of tinctures in accordance with the scheme for a further 2 months.

The results of the Wellness course: breast on the mammogram is not detected; no complaints.

Example 5. Patient U. (52)

Original diagnosis: uterine fibroids are medium in size, bilateral diffuse mastopathy, myelofibrosis.

Therapy: PR is eating collection in the form of a mixture of tincture of this scheme within 2 months.

The results of the Wellness course: breast on the mammogram was not found.

Therapy: admission fee in the form of a mixture of tincture of this scheme for another 4 months.

The results of the Wellness course: uterine fibroids are not detected.

Example 6. Patient O. (45) the Initial diagnosis of fibrocystic disease of the breast.

Complaints: pain in both Breasts, diffuse induration;

reduced working capacity.

Therapy: a dry collection of this scheme in the next three months.

The results of the Wellness course:

pain in the mammary glands do not bother;

on the mammogram visible positive dynamics;

the health and emotional recovered;

sleep is normalized.

The tests showed that the composition exhibits anti-inflammatory, analgesic, diuretic, antispasmodic and antiseptic action.

Therapeutic effects: reduces cysts, nodes in the mammary glands and other benign tumors, the normalization of the hormonal status, the prevention of cancer.

The composition can also be used in the form of Wellness tea as a dietary Supplement.

1. Composition for the treatment of gynecological diseases in women, including a mix of dried medicinal plants, calendula drugs is authorized (flowers), the cleaver (grass), marsh cinquefoil (grass), walnut (partitions), licorice (root) and Hypericum perforatum (grass), taken in the following ratio, including:

Calendula officinalis (flowers)1,0-2,5
Cleaver (grass)0.5 to 1.5
The cowberry (grass)1,5-3,0
Walnut (septum)1,5-3,0
Licorice (root)0.5 to 1.5
St. John's wort (herb)0.5 to 1.5

2. Composition for the treatment of gynecological disorders in women according to claim 1 further comprises the clover medicinal 0,5-1,5 hours

3. Composition for the treatment of gynecological diseases in women, including a mix of 30-40% alcohol tinctures of medicinal plants calendula (flowers), cleaver (grass), marsh cinquefoil (grass), walnut (partitions), licorice (root) and Hypericum perforatum (grass), taken in the following ratio, including:

Tincture of calendula (flowers)1,0-2,5
Tincture cleaver (grass)0.5 to 1.5
N the hour of marsh cinquefoil (grass) 1,5-3,0
Tincture of walnut (septum)1,5-3,0
The licorice (root)0.5 to 1.5
Tincture of St. John's wort (herb)0.5 to 1.5

4. Composition for the treatment of gynecological disorders in women according to claim 3 further comprises clover tincture dosage 0,5-1,5 hours



 

Same patents:

FIELD: biotechnology, in particular utilization of strain Lactobacillus salivarius UCC 118 for prophylaxis and/or treatment of undesired inflammation activity and cancer prophylaxis.

SUBSTANCE: human-original strain Lactobacillus salivarius UCC 118[NCIMB 40829] is isolated from dissected and washed human gastrointestinal tract. Strain application makes it possible to decelerate development of malignant diseases and to reduce undesired inflammation activity such as intestine inflammation or irritable colon.

EFFECT: strain for prophylaxis and/or treatment of undesired inflammation activity and cancer prophylaxis.

42 cl, 29 dwg, 1 tbl, 4 ex

FIELD: organic chemistry, biochemistry, medicine, pharmacy.

SUBSTANCE: invention relates to a compound and to all its enantiomeric and diastereomeric forms and pharmaceutically acceptable salts that are able to prevent extracellular release of inflammatory cytokines. Proposed compounds have the formula (I): wherein R represents: (a) -OR3 or (b) -NR4aR4b; R3 represents unsubstituted or substituted phenyl wherein substitutes are: (i) halogen atom; (ii) (C1-C6)-alkyl; (iii) trifluoromethyl; (iv) trichloromethyl; (v) tribromomethyl; (vi) cyano-group, and (vii) (C1-C6)-alkoxy-group; each R4a and Rb represents independently: (a) hydrogen atom or (b) -[C(R5aR5b)]xR6 wherein index x = 0-5; each R5a and R5b represents independently hydrogen atom, linear or branched (C1-C4)-alkyl, (C3-C7)-cyclic alkyl; R6 represents -OR7 or (C1-C4)-alkyl; R7 represents hydrogen atom or (C1-C4)-alkyl; R1 represents halogen-substituted phenyl; each among links R2a and R2b is chosen independently from the groups consisting of: (a) hydrogen atom; (b) -O(CH2)jR8; (c) -(CH2)jCO2R10; (d) -(CH2)jCON(R10)2; (e) a double bond when R2a and one R2b are chosen with formation of a double bond; (f) a ring when one R2a and one R2b are chosen with formation a ring and indicated ring is chosen from the group consisting of: (i) benzene and (ii) dioxalane; each R8 and R10 represents independently hydrogen atom or (C1-C4)-alkyl; j represents index from 0 to 5; m represents index from 1 to 3; n represents index from 1 to 3, and m + n = 4. Also, invention relates to a pharmaceutical composition based on abovementioned compounds that inhibits extracellular release of inflammatory cytokines, and a method for regulation of extracellular release of inflammatory cytokines.

EFFECT: valuable medicinal properties of compounds.

10 cl, 9 tbl, 11 ex

FIELD: organic chemistry, medicine, biochemistry, pharmacy.

SUBSTANCE: invention relates to the substituted pyrazoles, pharmaceutical compositions comprising these compounds and methods for their using in treatment of autoimmune diseases wherein cathepsin S is their mediating agent. Described substituted pyrazoles represent compounds of the formula (I): wherein a dotted line is placed near the group -C-R6 or absent, or it represents a bond; Y represents nitrogen atom or -CR20; Z represents nitrogen atom or -CR21; T represents nitrogen atom or -CR2; S represents nitrogen atom or -CR3 under condition that from 0 to 3 among S, T, Y and Z represent nitrogen atom, and additionally under condition that one among S, T, Y and Z can represent the group =N+-O- if other three are not nitrogen atom; R20 is chosen from hydrogen, halogen atom, hydroxy-, cyano-group, 4-7-membered heterocycle comprising nitrogen and oxygen atom; R21 represents hydrogen atom; R2 is chosen from hydrogen, halogen atom and hydroxy-group; R3 is chosen from hydrogen, halogen atom, (C1-C5)-alkoxy-group, (C1-C5)-alkyl, cyano-group, -RgRhN, 4-7-membered heterocyclyl comprising nitrogen and oxygen atom and -R17OC=O; R5 and R6 represent hydrogen atom; R7 and R8 can be combined in common and form optionally substituted 5-7-membered carbocylic or heterocyclic ring comprising nitrogen atom and wherein the indicated ring can be unsaturated or aromatic and this ring is substituted optionally with -Rt(C=O)- or -RtSO2; Rt represents (C1-C6)-alkyl; Rg, Rh and R17 represent (C1-C5)-alkyl; G represents (C3-C6)-alkanediyl; Ar represents monocyclic aryl ring optionally substituted from 1 to 3 substitutes chosen independently from halogen atom, (C1-C5)-alkyl and (C1-C5)-halogenalkyl; R32 represents hydrogen atom, (C1-C5)-alkyl, cyano-group, C1-C5)-hydroxyalkyl, -(C=O)NRvRx, -CHO or (C1-C6)-alkoxycarbonyl wherein each from Rv and Rx is chosen independently from hydrogen atom (H), (C1-C5)-alkyl, (C1-C5)-hydroxyalkyl, (C1-C5)-heterocyclyl comprising nitrogen and oxygen atom, (C1-C5)-heterocyclyl comprising nitrogen and oxygen atom-(C1-C5)-alkylene, (C1-C5)-aminoalkylene; Q represents -NR33, sulfur (S) or oxygen (O) atom; R33 represents hydrogen atom, (C1-C5)-alkyl, (C2-C5)-heterocyclyl comprising oxygen atom-(C1-C5)-alkylene, -R35OC=O and -R35OC=O; R35 represents (C1-C5)-alkyl, or their pharmaceutically acceptable salts, amides and esters, or their stereoisomeric forms.

EFFECT: improved for inhibition, valuable medicinal and biochemical properties of compounds and pharmaceutical composition.

25 cl, 3 tbl, 135 ex

FIELD: veterinary science.

SUBSTANCE: the present innovation deals with treating and preventing acute and chronic septic processes of any localization in animals, especially in case of inflammatory diseases of reproductive organs if females and, firstly, in cattle. It has been suggested a new homeopathic antiphlogistic veterinary preparation that contains Lachesis mutus, Pulsatilla, Sabina, Sepia and ACD-2 taken at equal ratios at the following dilutions of components: Pulsatilla D15, Sepia D6, Lachesis mutus D8,Sabina D3, ACD-2 D9. The innovation provides broadened variety of veterinary homeopathic antiphlogistic preparations.

EFFECT: higher efficiency of therapy.

3 ex, 4 tbl

FIELD: organic chemistry, biochemistry, medicine, pharmacy.

SUBSTANCE: invention relates to new derivatives of indole of the formula (1): and their pharmaceutically acceptable salts wherein represents a double bond; Z1 represents nitrogen atom (N), -CR5 wherein R5 represents hydrogen atom (H), (C1-C6)-alkyl, hydroxy-group (OH),(C1-C6)-alkoxy-group or halogen atom; Z2 at position 2 represents CR1 and at position it represents CA wherein each R1 means independently (C1-C6)-alkyl; A represents -Wi-COXjY wherein Y means -COR2 wherein R2 means -OR, -NR2, -NRNR2 or -NROR wherein each R represents independently hydrogen atom (H), (C1-C6)-alkyl, or (C5-C6)-heteroaryl comprising one or two heteroatoms in ring chosen from atoms N, O and S wherein each of them is substituted with one or some groups chosen from -NR'2, -OR', -COOR', (C1-C6)-alkyl, -CN, =O, and -SR' wherein each R' represents hydrogen atom (H) or (C1-C6)-alkyl and wherein two R or R' jointed to the same nitrogen atom (N) can form 3-8-membered ring chosen from the group comprising piperazine ring, morpholine ring, thiazolidine ring, oxazolidine ring, pyrrolidine ring, piperidine ring, azacyclopropane ring, azacyclobutane ring and azacyclooctane ring and wherein indicated ring can be substituted additionally with (C1-C6)-alkyl or -COO-(C1-C6)-alkyl; X represents unsubstituted (C1-C6)-alkylene, or Y means imidazole substituted with methyl group; i = 0; j = 0 or 1; R7 means hydrogen atom (H) or (C1-C6)-alkyl, -SOR, -SO2R, -RCO, -COOR, (C1-C6)-alkyl-COR, -CONR2, -SO2NR2,-CN, -OR, (C1-C6)-alkyl-SR, (C1-C6)-alkyl-OCOR, (C1-C6)-alkyl-COOR, (C1-C6)-alkyl-CN, or (C1-C6)-alkyl-CONR2 wherein each R represent independently hydrogen atom (H), (C1-C6)-alkyl or aryl that is substituted optionally with halogen atom, (C1-C4)-alkyl or (C1-C4)-alkoxy-group; or R7 represents methoxymethyl, methoxyethyl, ethoxymethyl, benzyloxymethyl or 2-methoxyethyloxymethyl; each R3 represent independently halogen atom, (C1-C6)-alkyl, -OR, -SR or -NR2 wherein R represents hydrogen atom (H) or (C1-C6)-alkyl; n = 0-3; L1 means -CO; L2 means (C1-C4)-alkylene optionally substituted with one or two groups of (C1-C4)-alkyl; each R4 is chosen independently from the group comprising (C1-C6)-alkyl, halogen atom, -OR, -NR2, -SR, -SOR, -SO2R, -RCO, -COOR, -CONR2, -SO2NR2 wherein each R represents independently hydrogen atom (H) or (C1-C6)-alkyl; or R4 represents =O; m = 0-4; Ar means aryl group substituted with from 0 to 5 substitutes chosen from the group comprising (C1-C6)-alkyl, halogen atom, -OR, -NR2, -SR, -SOR, -SO2R, -RCO, -COOR, -CONR2 and -SO2NR2 wherein each R represents independently hydrogen atom (H) or (C1-C6)-alkyl. Compounds of the formula (I) possess the inhibitory activity with respect to p38-α kinase that allows their using as components of the pharmaceutical composition.

EFFECT: valuable medicinal and biochemical properties of compounds and pharmaceutical composition.

63 cl, 3 tbl, 9 sch, 16 ex

FIELD: medicine, pharmaceutical industry.

SUBSTANCE: the suggested preparation for treating inflammatory skin diseases contains mud volcano mud as an active substance to be introduced into polymeric mixture, moreover, the mud should be introduced into swollen polymers during mixing and homogenization till the development of homogeneous gel mass at the ratio of 15-30:1.5-2.5 in weight portions, and, also, a conservant and a pharmaceutically acceptable solvent. Additionally, the preparation contains plant and/or mineral oils and an emulsifier.

EFFECT: higher efficiency of therapy.

4 cl, 4 ex

FIELD: medicine, pharmacy.

SUBSTANCE: invention relates to a soluble, carbonated, anti-inflammatory, analgesic and antipyretic agent as a tablet. Agent comprises acetylsalicylic acid, caffeine, ascorbic acid, paracetamol, basic component, acidic component and accessory substances. Invention provides the possibility of rapid release of the preparation in blood, decreasing time for undesirable contact of the preparation with stomach mucosa and its high activity.

EFFECT: valuable medicinal and pharmaceutical properties of agent.

6 cl, 6 tbl, 11 ex

FIELD: medicine, pharmaceutical industry, pharmacy.

SUBSTANCE: invention relates to an anti-inflammatory ointment with hypolipidemic effect. Proposed ointment comprises ephthylline-base for ointment, a statin wherein lescol (fluvastatin) is used as statin, and ephthylline comprises 40% of ephthiderm. Invention provides enhancing the curative effect and hypolipidemic effect and effects on enzymatic systems of biological membranes that results to prolongation of curative effect of ointment.

EFFECT: valuable medicinal properties of ointment.

3 cl, 2 tbl

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to new derivatives of piperidine of the general formula (I): or their nontoxic salts wherein R1 represents hydrogen atom, cyano-group; each R2 and R3 represents (C1-C8)-alkyl, (C3-C7)-cycloalkyl and others; each R4 and R5 represents hydrogen atom, (C1-C8)-alkyl and others; R6 represents hydroxyl group, (C1-C8)-alkoxy-group and others; m represents 0 or a whole number 1-4. Compounds of the formula (I) possess inhibitory activity with respect to PDE4 and can be used in medicine in treatment of inflammatory, diabetic, allergic and other diseases.

EFFECT: valuable medicinal properties of compounds.

10 cl, 11 tbl, 111 ex

FIELD: pharmaceutical industry and technology.

SUBSTANCE: invention relates to a method for preparing oily extracts from vegetable raw. Method for preparing gum-tree oily extract involves drying branches with 70% of leaves, not less, to the definite moisture index and milled followed by their treatment with electric activated liquid at the definite pH value and in the definite amount of raw mass at stirring and keeping for a definite time. Then prepared mass is wetted with ethyl alcohol, dried to the definite moisture value and extraction is carried out under definite conditions and filtered. Method allows decreasing extraction time and enhancing the yield of total amount of extractive substances.

EFFECT: improved preparing method of extracts.

5 tbl, 9 dwg, 16 ex

FIELD: medicine, gynecology.

SUBSTANCE: invention relates to treatment of chronic inflammatory diseases of uterus cervix and vagina. Method involves administration of tampons with Baldonskaya mud by every other day by their alternating with intravaginal applications of the mixture consisting of 8-9 ml of avocado oil, 2-3 drops of tea tree oil with manuca and 1-2 drops of eucalyptus oil by 12 procedures for a course. Simultaneously the method involves oral administration of 1-2 drops of essential oil with honey that is drunk with green or mint tea and by alternating the using thyme, lemon and tea tree oils with manuca wherein each component is taken for 21 day with 14 days breaks between these administrations. Then after 3 months break 1-2 drops of lavender oil is given by the same schedule. On the background of above said therapy method involves application once per a week on the patient body the oil mixture consisting of 100 ml of basic oil, 7-8 drops of lavender oil, 6-7 drops of lemon oil, 9-10 drops of thyme oil and 13-15 drops of rosemary oil in combination in 2 h the bath comprising 2 table spoons of salt "San Aktiv", 5-6 drops of thyme oil, 3-4 drops of rosemary oil, 1-2 drops of lemon at temperature 37°C for 20 min. Such carrying out the method provides the effective therapy in women with allergy to antibiotics.

EFFECT: improved treatment method.

1 ex

FIELD: medicine, gynecology.

SUBSTANCE: one should carry out intrauterine photohemotherapy with the help of special equipment for 45-50 min, 5 seances. Moreover, for interrupting acute manifestations of vaginal candidosis it is necessary to conduct therapy with antimycotic preparations once daily for 3 d, and since the 3d-4th d one should perform intrauterine photohemotherapy every other day at the mode "II", after photohemotherapy it is useful to continue antimycotic vaginal therapy for 3 d more. For treating chronic, relapsing forms of vaginal candidosis therapy with antimycotic preparations should be fulfilled locally every other day by alternating it with intrauterine photohemotherapy at modes "II" and "III". In 1.5-2 mo after the course of therapy it is suggested to carry out repeated course of intrauterine photohemotherapy at the mode "III", every other day, 5 seances.

EFFECT: higher efficiency of therapy.

1 cl, 1 ex

FIELD: medicine, gynecology, surgery.

SUBSTANCE: one should introduce 3.5%-chitosan ascorbate gel into fistulous channel that contains metronidasol at the dosage of 2 mg/ml, at the volume up to 20 ml once/2 d till complete fistula's closing. The present innovation enables to activate reparative processes and fistulous epithelization that favors for closing fistulous channel in earlier terms.

EFFECT: higher efficiency of therapy conducted.

2 ex

FIELD: gynecology.

SUBSTANCE: method is accomplished in the following order. First, daily sanations of vagina with 0.06% sodium hypochlorite solution are fulfilled for 10 min, total number of procedures being 5. If clinical-laboratory symptoms of inflammation disappear, eubiotics are then introduced intravaginally. In case of persistence of clinical-laboratory symptoms of inflammation, dosage forms with antimicrobial agents are introduced intravaginally or introduction of the latter is combined with oral administration of antibacterial preparations followed by intravaginal introduction of eubiotics.

EFFECT: accelerated immunocorrection leading to reduced treatment course to combined effect of sodium hypochlorite, antibiotics, and eubiotics.

4 ex

FIELD: medicine, gynecology, pharmacy.

SUBSTANCE: invention proposes using pimafucin (natamycin) as agent for treatment of bacterial vaginitis. Method for treatment of bacterial vaginitis involves intravaginal administration of pimafucin as 2% cream, 2 times per a day in morning and evening for 7-10 days and for first 3 days pimafucin-containing vaginal suppository in the dose 100 mg is administrated additionally in evening after administration of cream into vagina. Invention provides high effectiveness of treatment and clinical-etiological recovery in 92.3% of cases being without prescription of medicinal preparations. Method has no contraindications and can be used in all period of pregnancy and without adverse effects.

EFFECT: improved treatment method, enhanced effectiveness of agent and treatment.

2 cl, 1 ex

FIELD: medicine, gynecology.

SUBSTANCE: method involves using the following complex of medicinal agents: vaginal suppositories Hexicon, 1 suppository in the morning and night; Multitabs-maxi, 1 capsule, once per a day for 1 month; Eleutherococcus senticosus plant extract, 30 drops in the morning and in the daytime, before eating, for 2 months; Rokicen-RD, 1 spoon in the morning and night, 30 min before eating for 10 days and repeating this course of Rokicen-RD in 10 days. Invention promotes to arresting exacerbation disease for the shortest time on the background of absence of adverse effects and iatrogenic complications. Invention can be used for treatment of vaginal candidosis.

EFFECT: enhanced effectiveness of treatment.

3 ex

FIELD: veterinary medicine.

SUBSTANCE: poultry's diet during the first and second phases of egg yield should be supplemented with roxazym enzymatic complex at the ratio towards husk-bearing components being 0.007 - 0.009 : 20. The present innovation prevents inflammation of oviducal vagina in laying hens.

EFFECT: higher efficiency of prophylaxis.

3 ex

FIELD: medicine.

SUBSTANCE: method involves administering selective modulator of steroid sex hormones being in particular compounds of general formula(I) and some quantity of steroid sex hormones precursor selected from a group composed from dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-en-3β,17β-diol and compounds in vivo transformable into one of cited precursors. Bisphosphonates combined with selective estrogen receptor modulators and/or steroid sex hormones precursor are additionally introduced for medically treating and/or inhibiting osteoporosis progress.

EFFECT: enhanced effectiveness of treatment; excluded adverse side effects.

41 cl, 13 dwg, 4 tbl

The invention relates to medicine, gynecology, and can be used to treat inflammation of the vulva and vagina

The invention relates to the pharmaceutical industry and is used as an adjuvant in chronic inflammatory diseases of the urinary system in women

FIELD: pharmaceutical, cosmetic and food processing industry, in particular method for integrated utilization of larch wood.

SUBSTANCE: claimed method includes disintegration of larch wood having certain relative humidity in presence of ethanol up to specific particle size. Obtained ground pulp is extracted with ethanol under specific conditions, then solid and liquid phases are mechanically separated; ethanol with dissolved therein dihydroxyquercitine is mechanically recovered from liquid phase; liquid phase is filtered, boiling down; mixture of essential oils and fat organic acids useful in cosmetic industry is isolated from obtained concentrate. Dihydroxyquercitine is recovered form the rest organic phase. Whole process is carried out at specific temperature.

EFFECT: increased dihydroxyquercitine yield; simplified process; integral utilization of raw materials.

4 cl, 1 dwg, 3 ex

Up!